TRILOGY: Prasugrel, Clopidogrel Look Similar in ACS Patients
AT THE ANNUAL CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY
The TRILOGY ACS trial was sponsored by Eli Lilly and Daiichi Sankyo, the companies that market prasugrel (Effient). Dr. Roe said that he has received consulting fees from Eli Lilly and Daiichi Sankyo and other drug companies, research grants from Eli Lilly and other drug companies, and lecture fees from AstraZeneca and Janssen. Dr. De Caterina said that he has been a speaker for and received honoraria from Lilly, Daiichi Sankyo, AstraZeneca, and Bayer. Dr. Antman said that he served as lead investigator for the TRITON-TIMI 38 trial. Dr. Ohman said that he received grant support and travel expenses from Eli Lilly and Daiichi Sankyo, and consulting and lecture fees from other drug companies.
